DDrare: Database of Drug Development for Rare Diseases

Dihuang (DrugBank: Dihuang)

2 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	1
76	Pituitary gonadotropin secretion hyperthyroidism	1

46. Malignant rheumatoid arthritis [ 4,183 clinical trials, 2,538 drugs, (DrugBank: 401 drugs), 183 drug target genes, 219 drug target pathways]

Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 4,183 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2000037675	2020-10-01	2020-08-30	Clinical study of Shenshi Qianghuo Dihuang Decoction in the treatment of Rheumatoid arthritis from the perspective of ''7+1''	Clinical study of Shenshi Qianghuo Dihuang Decoction in the treatment of Rheumatoid arthritis from the perspective of ''7+1''	Rheumatoid arthritis	control group:Methotrexate;experimental group:Qianghuo Dihuang Decoction + Methotrexate;	Shanghai Traditional Chinese Medicine Hospital	NULL	Recruiting			Both	control group:72;experimental group:72;		China

76. Pituitary gonadotropin secretion hyperthyroidism [ 25 clinical trials, 41 drugs, (DrugBank: 11 drugs), 3 drug target genes, 10 drug target pathways]

Searched query = "Pituitary gonadotropin secretion hyperthyroidism", "Gonadotropin secreting pituitary adenoma", "Central precocious puberty", "Gonadotropin producing pituitary adenoma"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 25 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02920515 (ClinicalTrials.gov)	September 2012	16/8/2016	Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty	Multi-site Study of Comprehensive Treatment for Children Precocious Puberty	Central Precocious Puberty	Drug: Triptorlin or Leuprorelin;Drug: Zhibo dihuang pills;Drug: Dabu ying pills	Ruijin Hospital	Shanghai Children's Hospital;Shanghai Children's Medical Center;Xin Hua Hospital;Shanghai Children's Hospital;Shanghai Children's Medical Center;Xin Hua Hospital	Completed	2 Years	14 Years	Female	740	Phase 4	NULL